Skip to main content
. 2017 Jan 18;8(13):22203–22217. doi: 10.18632/oncotarget.14729

Table 1. Dysregulations in the PI3K pathway in HNSCC.

PI3K Pathway Component Type of alteration Tumor site
p85 Mutation [2, 11, 12]
PTEN Mutation [2, 1315]
Loss of heterozygosity [16, 17]
Reduced expression [16]
Not specified [2, 13, 14]
Oropharynx, hypopharynx, larynx [15]
Tongue, larynx, oral cavity [17]
Not specified [16]
AKT Mutation [2]
Activation [16, 18]
Copy number alteration [19]
Over-expression [20]
mTORC1 Mutation [2]
Activation [21]
EGFR Mutation [22, 23]
Activation [24]
Overexpression [24]
Laryngeal [23]
Not specified [22]

In cases where tumor sites were not specified, the table entry was left blank. Few studies [2, 11, 12] specified HPV status.